Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy
Clinical trial NCT02252887 · COMPLETED
Trial details
- NCT number
- NCT02252887
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-12
- Primary completion
- 2025-07-24
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.